A high-yielding CHO transient system: Coexpression of genes encoding EBNA-1 and GS enhances transient protein expression

Biotechnology Progress

Volumn 30, Issue 1, 2014, Pages 132-141

  Daramola, Olalekan ^a   Stevenson, Jessica ^a   Dean, Greg ^a   Hatton, Diane ^a   Pettman, Gary ^a   Holmes, William ^a   Field, Ray ^a  

^a MEDIMMUNE   (United States)

Author keywords

CHO cells; EBNA 1; Glutamine synthetase; Polyethylenimine; Transient gene expression

Indexed keywords

CHO CELL; EBNA-1; GLUTAMINE SYNTHETASE; POLYETHYLENIMINES; TRANSIENT GENE EXPRESSIONS;

AMINO ACIDS; ANTIBODIES; CELL CULTURE; DRUG PRODUCTS; GENE ENCODING; MOLECULAR BIOLOGY; VIRUSES;

GENE EXPRESSION;

CRICETULUS GRISEUS; HUMAN HERPESVIRUS 4;

EPSTEIN BARR VIRUS ANTIGEN; GLUTAMATE AMMONIA LIGASE; MONOCLONAL ANTIBODY; POLYETHYLENEIMINE; RECOMBINANT PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL ENGINEERING; CHO CELL LINE; CRICETULUS; EBNA-1; GENETICS; HAMSTER; METABOLISM; METHODOLOGY; TRANSIENT EXPRESSION;

CHO CELLS; EBNA-1; GLUTAMINE SYNTHETASE; POLYETHYLENIMINE; TRANSIENT GENE EXPRESSION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL ENGINEERING; CHO CELLS; CRICETINAE; CRICETULUS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GLUTAMATE-AMMONIA LIGASE; POLYETHYLENEIMINE; RECOMBINANT PROTEINS;

EID: 84893762730     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1809     Document Type: Article

References (68)

1. Matasci M, Hacker DL, Baldi L, Wurm FM. Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. Drug Discov Today: Technol. 2009;5:e37-e42.
2. Walsh G. Biopharmaceutical benchmarks 2010. Nat Biotechnol. 2010;28:917-924.
3. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22:1393-1398.
4. Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv. 2012;30:1158-1170.
5. Schiedner G, Hertel S, Bialek C, Kewes H, Waschutza G, Volpers C. Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection. BMC Biotechnol. 2008;8:13.
6. Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012;93:917-930.
7. Huang YM, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog. 2010;26:1400-1410.
8. Daramola O, Hatton D, Field R. Meeting the challenges of IgG expression: from antibody libraries to clinical supply. Bioprocess J. 2006;5:21-25.
9. Baldi L, Hacker DL, Adam M, Wurm FM. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett. 2007;29:677-684.
10. Geisse S. Reflections on more than 10 years of TGE approaches. Protein Expr Purif. 2009;64:99-107.
11. ® cell system. Biotechnol Bioeng. 2012;109:2250-2261.
12. Durocher Y, Butler M. Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol. 2009;20:700-707.
13. Pham PL, Kamen A, Durocher Y. Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol. 2006;34:225-237.
14. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res. 2008;36:e96.
15. Croset A, Delafosse L, Gaudry JP, Arod C, Glez L, Losberger C, Begue D, Krstanovic A, Robert F, Vilbois F, Chevalet L, Antonsson B. Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. J Biotechnol. 2012;161:336-348.
16. Gaudry JP, Arod C, Sauvage C, Busso S, Dupraz P, Pankiewicz R, Antonsson B. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation. Protein Expr Purif. 2008;58:94-102.
17. Shahrokh Z, Royle L, Saldova R, Bones J, Abrahams JL, Artemenko NV, Flatman S, Davies M, Baycroft A, Sehgal S, Heartlein MW, Harvey DJ, Rudd PM. Erythropoietin produced in a human cell line (dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines. Mol Pharm. 2011;8:286-296.
18. Suen KF, Turner MS, Gao F, Liu B, Althage A, Slavin A, Ou W, Zuo E, Eckart M, Ogawa T, Yamada M, Tuntland T, Harris JL, Trauger JW. Transient expression of an IL-23R extracellular domain fc fusion protein in CHO versus HEK cells results in improved plasma exposure. Protein Expr Purif. 2010;71:96-102.
19. Zeck A, Pohlentz G, Schlothauer T, Peter-Katalinic J, Regula JT. Cell type-specific and site directed N-glycosylation pattern of FcgammaRIIIa. J Proteome Res. 2011;10:3031-3039.
20. Derouazi M, Girard P, Van Tilborgh F, Iglesias K, Muller N, Bertschinger M, Wurm FM. Serum-free large-scale transient transfection of CHO cells. Biotechnol Bioeng. 2004;87:537-545.
21. Muller N, Derouazi M, Van Tilborgh F, Wulhfard S, Hacker DL, Jordan M, Wurm FM. Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems. Biotechnol Lett. 2007;29:703-711.
22. Liu C, Dalby B, Chen W, Kilzer JM, Chiou HC. Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol Biotechnol. 2008;39:141-153.
23. Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF. High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng. 2009;103:542-551.
24. Zhang X, Garcia IF, Baldi L, Hacker DL, Wurm FM. Hyperosmolarity enhances transient recombinant protein yield in Chinese hamster ovary cells. Biotechnol Lett. 2010;32:1587-1592.
25. Wulhfard S, Baldi L, Hacker DL, Wurm F. Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol. 2010;148:128-132.
26. Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM. A simple high-yielding process for transient gene expression in CHO cells. J Biotechnol. 2011;153:22-26.
27. Cain K, Peters S, Hailu H, Sweeney B, Stephens P, Heads J, Sarkar K, Ventom A, Page C, Dickson A. A CHO cell line engineered to express XBP1 and ERO1-Lα has increased levels of transient protein expression. Biotechnol Prog. 2013;29:697-706.
28. Hacker DL, Derow E, Wurm FM. The CELO adenovirus Gam1 protein enhances transient and stable recombinant protein expression in Chinese hamster ovary cells. J Biotechnol. 2005;117:21-29.
29. Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing bcl-x(L). Biotechnol Bioeng. 2008;101:567-578.
30. Kunaparaju R, Liao M, Sunstrom NA. Epi-CHO, #an episomal expression system for recombinant protein production in CHO cells. Biotechnol Bioeng. 2005;91:670-677.
31. Durocher Y, Loignon M. Process, vectors and engineered cell lines for enhanced large-scale transfection. US Patent 2011/0039339 A1, 2011.
32. Goepfert U, Kopetzki E. Protein Expression in rodent cells. US Patent 2010/0021965 A1, 2010.
33. Butler M, Spier RE. The effects of glutamine utilisation and ammonia production on the growth of BHK cells in microcarrier cultures. J. Biotechnol. 1984;1:187-196.
34. Cruz HJ, Freitas CM, Alves PM, Moreira JL, Carrondo MJ. Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells. Enzyme Microb Technol. 2000;27:43-52.
35. Suarez I, Bodega G, Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochem Int. 2002;41:123-142.
36. Enosawa S, Suzuki S, Fujino M, Amemiya H, Omasa T, Urayama S, Tanimura N, Suga K. An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell. Cell Transplant. 1997;6:537-540.
37. Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, Hoogenboom HR. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene. 1997;187:9-18.
38. Daramola O, Dean G, Hatton D, Stevenson J. Cell for transient expression and uses thereof. WO Patent 2011/033005 A2, 2011.
39. Gahn TA, Sugden B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol. 1995;69:2633-2636.
40. Mizuguchi H, Hosono T, Hayakawa T. Long-term replication of Epstein-Barr Virus-derived episomal vectors in the rodent cells. FEBS Lett. 2000;472:173-178.
41. Reisman D, Sugden B. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol. 1986;6:3838-3846.
42. Rosser MP, Xia W, Hartsell S, McCaman M, Zhu Y, Wang S, Harvey S, Bringmann P, Cobb RR. Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system. Protein Expr Purif. 2005;40:237-243.
43. Codamo J, Munro TP, Hughes BS, Song M, Gray PP. Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol. 2011;48:109-115.
44. Han X, Fang Q, Yao F, Wang X, Wang J, Yang S, Shen BQ. The heterogeneous nature of polyethylenimine-DNA complex formation affects transient gene expression. Cytotechnology. 2009;60:63-75.
45. Eberhardy SR, Radzniak L, Liu Z. Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium. Cytotechnology. 2009;60:1-9.
46. Thompson BC, Segarra CR, Mozley OL, Daramola O, Field R, Levison PR, James DC. Cell line specific control of polyethylenimine-mediated transient transfection optimized with "design of experiments" methodology. Biotechnol Prog. 2012;28:179-187.
47. van Berkel PH, Gerritsen J, Perdok G, Valbjorn J, Vink T, van de Winkel JG, Parren PW. N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG. Biotechnol Prog. 2009;25:244-251.
48. Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 2009;19:936-949.
49. Gramer MJ, Eckblad JJ, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer ET, Gerritsen J, van Berkel PH. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose. Biotechnol Bioeng. 2011;108:1591-1602.
50. Read EK, Park JT, Brorson KA. Industry and regulatory experience of the glycosylation of monoclonal antibodies. Biotechnol Appl Biochem. 2011;58:213-219.
51. Wacker C, Berger CN, Girard P, Meier R. Glycosylation profiles of therapeutic antibody pharmaceuticals. Eur J Pharm Biopharm. 2011;79:503-507.
52. Nallet S, Fornelli L, Schmitt S, Parra J, Baldi L, Tsybin YO, Wurm FM. Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells. N Biotechnol. 2012;29:471-476.
53. Kishida T, Asada H, Kubo K, Sato YT, Shin-Ya M, Imanishi J, Yoshikawa K, Mazda O. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells. J Biotechnol. 2008;133:201-207.
54. Frappier L. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses. 2012;4:1537-1547.
55. Mates JM, Perez-Gomez C, Nunez de Castro I, Asenjo M, Marquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol. 2002;34:439-458.
56. Birch JR, Mainwaring DO, Racher AJ. Use of glutamine synthetase (GS) expression system for the rapid development of highly productive mammalian cell processes. In: Knablein J, editor. Modern Biopharmaceuticals. Wiley-VCH Verlag GmbH & Co KGaA, Weinheim. 2005:809-832.
57. Huang YF, Wang Y, Watford M. Glutamine directly downregulates glutamine synthetase protein levels in mouse C2C12 skeletal muscle myotubes. J Nutr. 2007;137:1357-1362.
58. Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM. Reduced glutamine concentration improves protein production in growth-arrested CHO-DG44 and HEK-293E cells. Biotechnol Lett. 2012;34:619-626.
59. Vidal M, Wrighton C, Eccles S, Burke J, Grosveld F. Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors. Biochim Biophys Acta. 1990;1048:171-177.
60. Jones RJ, Smith LJ, Dawson CW, Haigh T, Blake NW, Young LS. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing. Virology. 2003;313:663-676.
61. Voedisch B, Patoux A, Sterkenburgh J, Buchs M, Barry E, Allard C, Geisse S. About making a CHO production cell line "research-friendly" by genetic engineering. BMC Proc. 2011;5 (Suppl 8):P132.
62. Kamranvar SA, Gruhne B, Szeles A, Masucci MG. Epstein-Barr Virus promotes genomic instability in burkitt's lymphoma. Oncogene. 2007;26:5115-5123.
63. Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA. 2009;106:2313-2318.
64. Kamranvar SA, Masucci MG. The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia. 2011;25:1017-1025.
65. Mates JM, Segura JA, Campos-Sandoval JA, Lobo C, Alonso L, Alonso FJ, Marquez J. Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol. 2009;41:2051-2061.
66. Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM. Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng. 2008;101:182-189.
67. Backliwal G, Hildinger M, Chenuet S, Dejesus M, Wurm FM. Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. N Biotechnol. 2008;25:162-166.
68. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, Andersen MR, Neff N, Passarelli B, Koh W, Fan HC, Wang J, Gui Y, Lee KH, Betenbaugh MJ, Quake SR, Famili I, Palsson BO, Wang J. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol. 2011;29:735-741.